brentuximab vedotin
takeda,seagen
['hodgkin', 'lymphoma', 'brentuximab']
 hodgkin studies at #ash22 showing 1) low rates of peripheral neuropathy with brentuximab &amp; vincristine in pediatric high risk hodgkin lymphoma (presented by susan parsons) 2) utility of a clinical scoring system chips in predicting efs (presented by ). 
Pediatric Oncologist @RoswellPark @OCH @Jacobs_Med_UB. Hodgkin Lymphoma, ALL. Mentoring next generation of physician researchers. Views are my own.